50694.1 IP-LS

Résumé

Long-Acting Human Growth Hormone Analogue by Sugar Polymer Bioconjugation

Textes supplémentaires

Abstract

Growth disorders in children are currently being treated with daily injections of human growth hormone (hGH). We have developed a long-acting hGH with the potential for weekly dosing. In the proposed project we aim at in vivo proof of concept by characterizing our candidate in relevant animal models

Participants

Michael Wetter

Kontaktperson

mwetter@biol.ethz.ch

ETH Zürich Michael Wetter Vladimir Prelog Weg 1-5 8093 Zürich ZH CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2021-02-28
Date de fin: 2022-08-31
Coûts totaux approuvés: CHF 449299.00
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

T410 Pharmaceuticals and related technologies 100.0%